U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685600) titled 'Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants' on June 29.

Brief Summary: The purpose of the study is to assess the pharmacokinetics (PK) of AZD4144 when administered alone and in combination with itraconazole in healthy participants.

Study Start Date: July 30

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: AZD4144

AZD4144 will be administered orally.

DRUG: AZD4144

AZD4144 will be administered as an IV infusion.

DRUG: Itraconazole

Itraconazole will be administered orally.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Disclaimer: Curate...